Clinical trial · Observational
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Patients Meeting Chinese Lynch Syndrome Criteria
Diagnosis of Lynch Syndrome Based on Next-generation Sequencing in Colorectal Cancer Patients Meeting Chinese Lynch Syndrome Criteria: An Open-label and Multi-center Study.
NCT03046849CI-TRIAL-00053221completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to find out the proportion of patients diagnosed with Lynch syndrome in colorectal cacner patients meeting Chinese Lynch syndrome criteria. Besides, this study is aimed to analyze the clinical characteristics and germline mutation of Lynch syndrome in Chinese population.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lynch Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| next-generation sequencing | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pathogenic germline mutation
- timeFrame
- Upon completion of study, on average 2 years.
- description
- Pathogenic germline mutation using next-generation sequencing with a targeted panel.
Secondary outcomes (1)
- measure
- Variant of uncertain significance of germline mutation
- timeFrame
- Upon completion of study, on average 2 years.
- description
- Variant of uncertain significance using next-generation sequencing with a targeted panel.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
For probands, the inclusion criteria: all of the following three points should be satisfied: 1. One of the colorectal cancer patients from families meeting Chinese Lynch syndrome criteria. Chinese Lynch syndrome criteria: In a pedigree, there were at least 2 patients with histological-proven colorectal cancer, and among these, at least two patients are first-degree relatives of each other. Besides, any one of the following three points should be satisfied in the pedigree: A. at least one patients with multiple primary colorectal carcinoma/adenoma, either synchronously or metachronously. B. at least one colorectal cancer diagnosed before 50 years old. C. in the pedigree, at least one patient diagnosed with other Lynch syndrome associated cancer (ie, gastric, endometrial, small bowel, ureter, or renal-pelvic, ovarian and hepatobiliary cancers). 2. With sufficient blood to test; 3. Agree to provide basic information, clinical information and family history of cancer information. For probands, the exclusion criteria: With at least one blood relative with known pathogenic germline mutation(s). For blood relatives verifying germline mutation, the inclusion criteria: all of the following three points should be satisfied: 1. First- to second-degree blood relatives of probands with germline mutation(s). 2. With sufficient blood to test. 3. Agree to provide basic information, clinical information and family history of cancer information. For blood relatives verifying germline mutation, the exclusion criteria: Blood relatives who refuse to test.
References
Publications (0)
Data not yet available
No reference posted for this study.